Vial
Vial is a hyper scalable biotech — advancing programs into the clinic with lower cost trials and computationally designed therapeutics.
Xlumena
Designed minimally invasive endoscopic tools for therapeutic and diagnostic procedures in gastroenterology. Acquired by Boston Scientific in 2015.
ViaCyte
Develops cell replacement therapies for diabetes. ViaCyte was acquired by Vertex Pharmaceuticals in 2022.
Twist Bioscience
Synthesizes DNA and provides custom DNA products for research and development.
True North Therapeutics
Focused on developing treatments for rare diseases mediated by the complement system. Acquired by Bioverativ in 2017.